Stock Track | SINOPHARM Plummets 5.05% Intraday on Weak Q1 2026 Results Showing Revenue and Profit Decline

Stock Track04-27

SINOPHARM's stock plummeted 5.05% during intraday trading on Monday, following the release of the company's first-quarter 2026 financial results.

The decline was triggered by disappointing quarterly figures that showed both revenue and profit contraction. Sinopharm reported total operating revenue of RMB 140.77 billion for Q1 2026, representing a 0.63% year-over-year decrease. More significantly, net profit attributable to shareholders fell 2.95% to RMB 1.41 billion, with basic earnings per share dropping to RMB 0.45 from RMB 0.47 in the same period last year.

Further analysis reveals broader weakness in the company's performance, including a narrowed gross margin and soft results across key subsidiaries. The medical equipment arm reported a steep 20.41% decline in operating profit, while operating cash flow deteriorated significantly. These results disappointed investors, leading to the stock hitting a six-month low during the session.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1148447055?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-04-27 14:48","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1148447055","market":"sg","top_or_hot":-1,"title":"Stock Track | SINOPHARM Plummets 5.05% Intraday on Weak Q1 2026 Results Showing Revenue and Profit Decline","media":"Stock Track","content":"<p>SINOPHARM's stock plummeted 5.05% during intraday trading on Monday, following the release of the company's first-quarter 2026 financial results.</p><p>The decline was triggered by disappointing quarterly figures that showed both revenue and profit contraction. Sinopharm reported total operating revenue of RMB 140.77 billion for Q1 2026, representing a 0.63% year-over-year decrease. More significantly, net profit attributable to shareholders fell 2.95% to RMB 1.41 billion, with basic earnings per share dropping to RMB 0.45 from RMB 0.47 in the same period last year.</p><p>Further analysis reveals broader weakness in the company's performance, including a narrowed gross margin and soft results across key subsidiaries. The medical equipment arm reported a steep 20.41% decline in operating profit, while operating cash flow deteriorated significantly. These results disappointed investors, leading to the stock hitting a six-month low during the session.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | SINOPHARM Plummets 5.05% Intraday on Weak Q1 2026 Results Showing Revenue and Profit Decline</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | SINOPHARM Plummets 5.05% Intraday on Weak Q1 2026 Results Showing Revenue and Profit Decline\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2026-04-27 14:48</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>SINOPHARM's stock plummeted 5.05% during intraday trading on Monday, following the release of the company's first-quarter 2026 financial results.</p><p>The decline was triggered by disappointing quarterly figures that showed both revenue and profit contraction. Sinopharm reported total operating revenue of RMB 140.77 billion for Q1 2026, representing a 0.63% year-over-year decrease. More significantly, net profit attributable to shareholders fell 2.95% to RMB 1.41 billion, with basic earnings per share dropping to RMB 0.45 from RMB 0.47 in the same period last year.</p><p>Further analysis reveals broader weakness in the company's performance, including a narrowed gross margin and soft results across key subsidiaries. The medical equipment arm reported a steep 20.41% decline in operating profit, while operating cash flow deteriorated significantly. These results disappointed investors, leading to the stock hitting a six-month low during the session.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"01099","symbol_name":"国药控股","start_time":0,"source_url":"","article_id":"1148447055","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1148447055","pubTimestamp":1777272527,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"SINOPHARM's stock plummeted 5.05% during intraday trading on Monday, following the release of the company's first-quarter 2026 financial results.The decline was triggered by disappointing quarterly...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"01099":"国药控股"},"translate_title":"股票赛道|2026年Q1业绩疲弱营收利润下滑国药控股盘中暴跌5.05%","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01099":1},"content_text":"SINOPHARM's stock plummeted 5.05% during intraday trading on Monday, following the release of the company's first-quarter 2026 financial results.The decline was triggered by disappointing quarterly figures that showed both revenue and profit contraction. Sinopharm reported total operating revenue of RMB 140.77 billion for Q1 2026, representing a 0.63% year-over-year decrease. More significantly, net profit attributable to shareholders fell 2.95% to RMB 1.41 billion, with basic earnings per share dropping to RMB 0.45 from RMB 0.47 in the same period last year.Further analysis reveals broader weakness in the company's performance, including a narrowed gross margin and soft results across key subsidiaries. The medical equipment arm reported a steep 20.41% decline in operating profit, while operating cash flow deteriorated significantly. These results disappointed investors, leading to the stock hitting a six-month low during the session.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-2","news_tag":"movement","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.2","shortVersion":"4.42.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1148447055","isCrawlerRequest":true}